Abstract
The aim of this study was to evaluate the association between inflammatory and metabolic markers and short-time outcome with acute ischemic stroke subtypes. A total of 121 patients was classified according to TOAST criteria, such as large artery atherosclerosis (LAAS), lacunar infarct (LAC), cardioembolic infarct (CEI), other determined etiology (ODE), and undetermined etiology (UDE). The functional impairment was evaluated within the first eight hours of stroke and the outcome after three-month follow-up using the modified Rankin Scale. Blood samples were obtained up to 24 h of stroke. Compared with 96 controls, patients with LAAS, CEI, and LAC subtypes showed higher levels of white blood cells, high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), metalloproteinase 9 (MMP-9), glucose, and iron (p < 0.05); and lower high-density lipoprotein cholesterol (HDL-C) (p < 0.0001); platelets, insulin, insulin resistance, and homocysteine were higher in LAC (p < 0.0001); ferritin was higher in LAAS (p < 0.0001); and total cholesterol (TC) was lower in LAAS and CEI (p < 0.01). When stroke subtypes were compared, insulin was higher in LAAS vs. LAC and in LAC vs. CEI (p < 0.05); and TC was lower in LAAS vs. LAC (p < 0.05). Outcome and rate of mortality after three-month were higher in LAAS vs. LAC (p < 0.001 and p = 0.0391 respectively). The results underscored the important role of the inflammatory response and metabolic changes in the pathogenesis of ischemic stroke subtypes that might be considered on the initial evaluation of stroke patients to identify those that could benefit with individualized therapeutic strategies that taken into account these markers after acute ischemic event.
Similar content being viewed by others
References
Abubakar AS, Okubadejo NU, Ojo OO et al (2013) Relationship between admission serum C-protein and short-term outcome following acute ischemic stroke at a tertiary health institution in Nigeria. Niger J Clin Pract 16:320–324
Adams HP Jr, Bendixen BH, Kappelle JJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions of use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Anuk T, Assayag EB, Rotstein R et al (2002) Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand 106:196–199
Aquil N, Begum I, Ahmed A et al (2011) Risk factors in various subtypes of ischemic stroke according to TOAST criteria. J Coll Physicians Surg Pak 21:280–283
Barrett KM, Brott TG, Brown RD Jr, Frankel MR, Worrall BB, Silliman SL, Case LD, Rich SS, Meschia JF, Ischemic Stroke Genetics Study Group (2007) Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis 16:34–39
Bonita R, Beaglehole R (1988) Modification of Rankin scale: recovery of motor function after stroke. Stroke 19:1497–1500
Brazil (2013a) Ministry of Health. System of Mortality Information (SIM) and IBGE. [Internet] [accessed 2013a Dec 01]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2011/c08.def
Brazil (2013b) IBGE. Brazilian Institute of Geography and Statistics (2011) Characteristics of the Population and Households: Results of the Universe. Available in://http://www.ibge.gov.br/english/estatistica/populacao/censo2010/caracteristicas_da_populacao/default_caracteristicas_da_populacao.shtm. Accessed in July 16, 2013b
Brazil (2013c) Manual de Rotinas para atendimento ao AVC. Editora Ministério da Saúde. Brasília; Ministério da Saúde
Calles-Escandon J, Mirza SA, Sobel BE et al (1998) Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47:290–293
Canova CR, Courtin C, Reinhart WH (1999) C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis 147:49–53
Castellanos M, Leira R, Tejada J et al (2002) Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry 76:691–695
Chaudhuri JR, Mridula KR, Umamahesh M, Swathi A, Balaraju B, Bandaru VC (2013) High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iran J Neurol 12:92–97
Chin BS, Blann AD, Gibbs CR, Chung NA, Conway DG, Lip GY (2003) Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest 33:941–948
Cojocarui IM, Cojocaru M, Sapira V, Socoliuc G, Hertea C, Paveliu S (2012) Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke. Rom J Intern Med 50:155–158
Conway DS, Buggins P, Hughes E, Lip GY (2004) Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148:462–466
Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK (2005) Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case–control study of their association with risk of stroke. J Stroke Cerebrevasc Dis 14:29–35
Dávalos A, Castillo J, Marrugat J et al (2000) Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology 54:1568–1574
de Almeida ER, Reiche EM, Kallaur AP et al (2013) The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. Biomed Res Int 2013:836790
Demir R, Ulvi H, Özel L, Özdemir G, Güzelcik M, Aygül R (2012) Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke. Acta Neurol Belg 112:351–356
Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32:917–924
Di Napoli M, Schwaninger M, Cappelli R et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36:1316–1329
Dong J, Fujii S, Goto D et al (2003) Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 26:723–729
Emsley HC, Smith CJ, Gavin CM et al (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139:93–101
Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q (1997) Testing the validity of the lacunar hypothesis: the Northen Manhattan Stroke Study Experience. Neurology 48:1204–1211
Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics −2014 update: a report from the american heart association. Circulation 129:e28–e292
Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in San Antonio Heart Study. Diabetes Care 20:1087–1092
Hassan A, Hunt BJ, O’Sullivan M et al (2004) Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127(Pt 1):212–219
Herrmann O, Tarabin V, Suzuki S et al (2003) Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 23:406–415
Intiso D, Zarrelli MM, Lagioia G et al (2004) Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci 24:390–396
Jackson CA, Hutchinson A, Dennis MS et al (2010) Different risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy? Stroke 41:624–629
Jickling GC, Xu H, Stamova B et al (2010) Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol 68:681–692
Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS (1996) Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 27:1765–1769
Katsiki N, Ntaios G, Vemmos K (2011) Stroke, obesity and gender: a review of the literature. Maturitas 69:239–243
Kaul S, Sunitha P, Suvarna A, Meena AK, Uma M, Reddy JM (2002) Subtypes of Ischemic Stroke in a Metropolitan City of South India (One year data from a hospital based stroke registry). Neurol India 50(Suppl):S8–S14
Kelly PJ, Morrow JD, Ning M et al (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: The biomarker evaluation for antioxidant therapies in stroke (BEAT-Stroke) Study. Stroke 39:100–104
Kerr R, Stirling D, Ludlam CA (2001) Interleukin-6 and hemostasis. Br J Haematol 115:3–12
Kisialiou A, Pelone G, Carrizzo A et al (2012) Blood biomarkers in acute ischemic stroke patients: higher is worse or better? Immun Ageing 9:22
Kreisel SH, Stroick M, Reuter B, Senn E, Hennerici MG, Fatar M (2012) MMP-2 concentrations in stroke according to etiology: adjusting for enzyme degradation in stored deep-frozen serum and other methodological pitfalls. J Clin Neurosci 19:1564–1567
Kuhlmann CR, Librizzi L, Closhen D et al (2009) Mechanisms of C-reactive protein-induced blood–brain barrier disruption. Stroke 40:1458–1466
Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P (2006) Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37:2018–2023
Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371:1513–1518
Lentz SR, Sobey CG, Piegors DJ et al (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 98:24–29
Liaskou E, Jeffery LE, Trivedi PJ, Reynolds GM, Suresh S, Bruns T, Adams DH, Sansom DM, Hirschfield GM (2014) Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology 147:221–232
Licata G, Tuttolomondo A, Corrao S et al (2006) Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol 19:639–646
Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Sciacca D, Pinto A (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischemic stroke. Tromb Haemost 101:929–937
Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481–1488
Liu X, Xu G, Wu W, Zhang R, Yin Q, Zhu W (2006) Subtypes and one-year survival of first-ever stroke in Chinese patients: The Nanjing Stroke Registry. Cerebrovasc Dis 22:130–136
Liuzzo G, Biasucci LM, Trotta G et al (2007) Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50(15):1450–1458
Lucivero V, Prontera M, Mezzapesa DM et al (2007) Different roles of matrix metalloproteinases −2 and −9 after human ischemic stroke. Neurol Sci 28:165–170
Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT (2004) Novel diagnostic test for acute stroke. Stroke 35:57–63
Maly K, Schirmer M (2015) The story of CD4+ CD28- T cells revisited: solved or still ongoing? J Immunol Res 2015:348746
Manso H, Krug T, Sobral J et al (2010) Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40
Manso H, Krug T, Sobral J et al (2011) Variants in the inflammatory IL6 and MPO genes modulate stroke susceptibility through main effects and gene-gene interactions. J Cereb Blood Flow Metab 31:1751–1759
Montaner J, Alvarez-Sabín J et al (2001) Matrix metalloproteinase expression is related to hemorrhagic transformation after stroke. Stroke 32:2762–2767
Montaner J, Rovira A, Molina CA et al (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23:1403–1407
Montaner J, Perea-Gainza M, Delgado P et al (2008) Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39:2280–2287
Morancho A, Rosell A, García-Bonilla L, Montaner J (2010) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann N Y Acad Sci 1207:123–133
Morita A, Nakayama T, Soma M (2006) Association between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 19:593–600
Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR (1999) C-reactive protein and outcome after ischemic stroke. Stroke 30:981–985
Murakami Y, Saito K, Hara A et al (2005) Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J Neurochem 93:1616–1622
Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2002) T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105:570–575
Oh MS, Yu KH, Chu MK et al (2011) Long-term prognosis of symptomatic isolated middle cerebral artery disease in Korean stroke patients. BMC Neurol 11:138
Oliveira-Filho J, Martins SC, Pontes-Neto OM et al (2012) Guidelines for acute ischemic stroke treatment: part I. Arq Neuropsiquiatr 70:621–629
Osmani AH, Durrani RK, Ara J (2010) Comparison of outcome in different types of stroke due to cerebral ischemia. Coll Physicians Surg Pak 20:42–46
Parreira JS, Kallaur AP, Lehmann MF et al (2015) Tumor necrosis beta Ncol polymorphism (rs909252) is associated with inflammatory and metabolic markers in acute ischemic stroke. Metab Brain Dis 30:159–167
Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168
Pena SD, Di Pietro G, Fuchshuber-Moraes M et al (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6:e17063
Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA (2009) Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 40:1032–1037
Pickering TG, Hall JE, Appel LJ et al (2005) Recommendation for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161
Qamirani E, Ren Y, Kuo L et al (2005) C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 25:995–1001
Rajeshwar K, Kaul S, Al-Hazzani A et al (2012) C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome. Inflammation 35:978–984
Ramos-Fernandez M, Bellolio MF, Stead LG (2011) Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 20:47–54
Rautou PE, Vion AC, Amabile N et al (2011) Microparticles, vascular function, and atherothrombosis. Circ Res 109:593–606
Rigal M, Ruidavets JB, Viguier A et al (2007) Lipoprotein (a) and risk of ischemic stroke in young adults. Neurol Sci 252:39–44
Rohde LE, Hennekens CH, Ridker PM (1999) Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 19:1595–1599
Romano M, Sironi M, Toniatti C et al (1997) Role of interleukin-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6:315–325
Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood–brain barrier opening after reperfusion in rat brain. Stroke 29:2189–2195
Sacco SE, Whisnant JP, Broderock JP et al (1991) Epidemiological characteristics of lacunar infarction in a population. Stroke 22:1236–1241
Stamler JS, Osborne JA, Jaraki O et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308–318
Syed NA, Khealani BA, Ali S et al (2003) Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc 53:584–588
Tarkowski E, Rosengren L, Blomstrand C et al (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393–1398
Tarkowski E, Rosengren L, Blomstrand C et al (1999) Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30:321–327
Tawakol A, Omland T, Gerhard M et al (1997) Hyperhomocysteinemia is associated with impaired endothelium dependent vasodilation in humans. Circulation 95:1119–1121
Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875
Townsend N, Wickramasinghe K, Bhatnagar P, Smolina K, Nichols M, Leal J, Luengo-Fernandez R, Rayner M (2012) Coronary heart disease statistics 2012 edition. British Heart Foundation, London
Tuttolomondo A, Raimondo DD, Pecoraro R et al (2010) Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 213:311–318
Tuttolomondo A, Raimondo DD, Pecoraro R et al (2012) Inflammation in ischemic stroke subtypes. Curr Pharmacol Des 18:4289–4310
Tuttolomondo A, Pecoraro R, Casuccio A et al (2015) Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers. Medicine 94(20):e813
Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ (2005) Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke 6:1984–1987
Vukasovic I, Tesija-Kuna A, Topic E, Supanc V, Demarin V, Petrovcic M (2006) Matrix metalloproteinases and their inhibitors in different acute stroke subtypes. Clin Chem Lab Med 44:428–434
Wall RT, Harlan JM, Harker LA et al (1980) Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18:113–121
Wardlaw JM, Doubal F, Armitage P et al (2009) Lacunar stroke is associated with diffuse blood–brain barrier dysfunction. Ann Neurol 65:194–202
Waterer GW, Wunderink RG (2003) Science review: Genetic variability in the systematic inflammatory response. Crit Care 7:308–314
Whiteley W, Wardlaw J, Dennis M et al (2012) The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 43:86–91
Winbeck K, Poppert H, Etgen T, Conrad B, Sander D (2002) Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33:2459–2464
Woo KS, Chook P, Lolin YI et al (1997) Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96:2542–2544
Woo D, Gebel J, Miller R et al (1999) Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 30:2517–2522
Wu TH, Chien KL, Lin HJ et al (2013) Total white blood cell count or neutrophil count predict ischemic stroke events among adult Taiwanese: report from a community-based cohort study. BMC Neurol 13:7
Xu H, Tang Y, Liu DZ et al (2008) Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atheroscleroticstroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab 28:1320–1328
Yonemoto K, Doi Y, Hata J et al (2011) Body mass index and stroke incidence in a Japanese community: the Hisayama study. Hypertens Res 34:274–279
Acknowledgments
The study was supported by Institutional Program for Scientific Initiation Scholarship (PIBIC) of the National Council for Scientific and Technological Development (CNPq); State University of Londrina (PROPPG); and Bayer HealthCare. We thank the University Hospital of State University of Londrina and HUTec Foundation for technical and administrative supports.
Conflict of interest
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehmann, M.F., Kallaur, A.P., Oliveira, S.R. et al. Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes. Metab Brain Dis 30, 1417–1428 (2015). https://doi.org/10.1007/s11011-015-9731-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-015-9731-8